DoW Breast Cancer, Clinical Research Extension Award
Open. Closes November 18, 2026, 27 days from October 22, 2026, as posted on Grants.gov. Posted by Defense Health Agency Contracting Activity - DHACA, opportunity number HT942526BCRPCREA2.
Get a first draft in your own AI assistant
Free, no account. Add CedarGrant to Claude, then paste this into a new chat. Your assistant reads the official notice, asks you a few questions and writes a first draft in the notice's format.
Use CedarGrant to help me apply for DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2): https://simpler.grants.gov/opportunity/363671
Already writing? Paste this instead, with your draft attached:
Use CedarGrant to make a Requirements Map and run a Reviewer Panel on my draft for HT942526BCRPCREA2.
Notice facts
| Agency | Defense Health Agency Contracting Activity - DHACA |
|---|---|
| Opportunity number | HT942526BCRPCREA2 |
| Assistance listing | 12.420 |
| Funding instrument | Grant |
| Category | Science and Technology and other Research and Development |
| Posted | September 3, 2026 |
| Closes | November 18, 2026 |
| Award range | Not stated |
| Expected number of awards | 1 |
| Total program funding | $8,400,000 |
| Cost sharing or matching | Not required, per the notice |
| Applicant types listed | Unrestricted (any type of organization, subject to the notice's eligibility text) |
| Additional eligibility information | None listed |
| Where to apply | Check the notice for where and how to submit. |
As posted on Grants.gov, checked October 21, 2026. CedarGrant lists what the notice states; it does not judge whether an organization is eligible. The official notice and its modifications control.
Summary from the notice
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or…
Official notice and documents
- HT942526BCRPCREA2_GG.pdf (Full Announcement)
Similar open grants
| Closes | Grant | Agency | Award range |
|---|---|---|---|
| October 22, 2026 0 days left | DoW Arthritis Clinical Research Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Arthritis Translational Research Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Autism Career Development Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Autism Clinical Trial Award | Defense Health Agency Contracting Activity - DHACA | Not stated |
| October 22, 2026 0 days left | DoW Autism Idea Development Award | Defense Health Agency Contracting Activity - DHACA | Not stated |